Solution
Industries
Resources
About

Therapeutics and Diagnostics for Women's Disorders

Report Code: BIO043D

Publish Date: Mar 2009

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The U.S. market for therapeutics and diagnostics for women’s disorders was worth $29.9 billion in 2008. This should increase to $50.0 billion in 2013, for a compound annual growth rate (CAGR) of 10.9%.
  • The rheumatoid arthritis and osteoporosis segment has the largest share of the market, generating $10.6 billion in 2008. This is expected to grow at a CAGR of 11.5% to reach $18.2 billion in 2013.
  • Reproductive related therapies and diagnostics currently have the second largest market share, worth $5.9 billion in 2008. This should reach $7.5 billion in 2013, for a CAGR of 5.0%.

INTRODUCTION 

STUDY GOALS AND OBJECTIVES
 
This BCC Research report, Therapeutics and Diagnostics for Women’s Disorders, provides an overview of products included in this market, and detailed analyses of markets and competitive environments. The study includes information about significant products, players, issues and trends, and other information affecting the women’s disorders and diseases industry.
 
REASONS FOR DOIING THE STUDY
 
New therapeutics and diagnostics have emerged in the last few years that have had a significant impact on women’s health. This study updates the previous BCC New Therapeutics and Diagnostics for Women’s Disorders with what has been happening in this arena since 2005.
 
This area covers a wide variety of products and disorders that affect predominantly women. Ongoing patient management studies will increase the number of indications. Keeping in touch with these applications for the various products is good business practice. This study will provide the reader with the knowledge to adequately view and assess the women’s healthcare movement and provide insights into the market potentials.
 
SCOPE OF REPORT
 
This newly updated BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the market for women’s therapeutic and diagnostic products. The geographical scope of this study is U.S. based. The report identifies markets in general segments:
  • Autoimmune diseases
  • Women’s cancer
  • Gynecological diseases and infections
  • Kidney and urological diseases and infections
  • Reproductive-related therapies and diagnostics
  • Rheumatoid arthritis and osteoporosis 
Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.
 
METHODOLOGY
 
The information for this BCC Research report was obtained through primary and secondary data collection methods. Primary methods included interviews with more than 50 key executives, product managers, clinical specialists and other related key personnel involved in the women’s healthcare industry. Secondary sources included published literature, investment reports, company literature, and various business journals that have emphasis on women’s health and related areas.
 
Market data for this report pertains to the U.S. market and uses U.S. dollars at the manufacturers’ level. The base year of the report is 2008, with historical data provided for 2006 and 2007, and forecast data provided for 2013. Historical, base year and forecast data are provided for each market segment of the report. Growth rates are determined through a compilation of data including past trends, future trends, demographics, incidence, mortality, products in research and development, and current product growth, etc. Competitor market share estimates are provided for each market segment for the 2008 base year.
 
ANALYSTS CREDENTIALS
 
Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals, medical devices, animal health, and emerging healthcare technologies. Ms. Elder has more than 14 years’ experience in the healthcare industry, specializing in market research for the past 11 years. This experience has given her substantial insights into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.
 
Tracy Cotthoff is an experienced critical care/wound care nurse in a high-volume burn center. Ms. Cotthoff has been in the medical field for over 14 years. This experience has given her a vast knowledge of medical practices and advances in the industry and new technologies. Her experience in the medical field includes EMT training and nursing, including critical care nursing, which has allowed for her substantial insight into the workings of the healthcare industry.
 
BCC RESEARCH ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of market research reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers 
DISCLAIMER
 
Neither the author nor BCC Research assumes any responsibility for the information in this report or for its use. All material in the report is intended to be as reliable as possible, and was gathered, analyzed, and written in a professional manner. The author assumes no liability for any loss or damage that may result from any reliance on any materials or information developed and presented in the report. This report is not a legal or accounting document, nor is it an endorsement of any material, product, or process. Much of the information developed and presented is of a speculative nature, and must be treated as such; this last statement is especially true for a politically and economically sensitive subject such as this one in a very uncertain political and economic climate.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Therapeutics and Diagnostics for Women's Disorders198Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY2Free
Chapter- 3: INDUSTRY OVERVIEW26Free
Chapter- 4: AUTOIMMUNE DISEASES26Free
Chapter- 5: WOMEN'S CANCERS27Free
Chapter- 6: GYNECOLOGICAL INFECTIONS AND SEXUALLY TRANSMITTED DISEASES21Free
Chapter- 7: KIDNEY AND UROLOGIC DISEASES AND CONDITIONS13Free
Chapter- 8: REPRODUCTIVE-RELATED THERAPEUTICS AND DIAGNOSTICS25Free
Chapter- 9: RHEUMATOID ARTHRITIS AND OSTEOPOROSIS18Free
Chapter- 10: MARKET SUMMARY2Free
Chapter- 11: INDUSTRY PARTICIPANTS BY TYPE35Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 45

  • Summary Table: U.S. MARKET FOR NEW THERAPEUTICS AND DIAGNOSTICS FOR WOMEN’S DISORDERS BY SEGMENT, THROUGH 2013
  • Table 1: ESTIMATES OF ANTICIPATED U.S. LIFE EXPECTANCY AT BIRTH AND PROJECTIONS BY GENDER, 2000-2020
  • Table 2: PROJECTED GLOBAL FEMALE POPULATION BY AGE, THROUGH 2030
  • Table 3: PROJECTED UNITED STATES FEMALE POPULATION BY AGE, THROUGH 2030
  • Table 4: INSURANCE COVERAGE OF CONTRACEPTIVES BY STATE
  • Table 5: U.S. SEXUAL DYSFUNCTION PRODUCTS FOR WOMEN IN DEVELOPMENT, 2008
  • Table 6: U.S. PRESCRIPTION GENERIC DRUG APPROVALS FOR CONSTRACEPTION BY COMPANY AND APPROVAL DATE, 2003-2008
  • Table 7: U.S. MARKET FORECAST FOR AUTOIMMUNE DISEASES BY PRODUCT SEGMENT, THROUGH 2013
  • Table 8: MANUFACTURERS OF AUTOIMMUNE DISEASE PRODUCTS, 2008
  • Table 9: U.S. SUMMARY OF AUTOIMMUNE DISEASE MARKET BY COMPETITOR REVENUES, 2008
  • Table 10: U.S. AUTOIMMUNE DISEASE PRODUCTS IN DEVELOPMENT, 2008
Sample Report

Recent Reports

Biologic Therapies for Wound Care: Technologies and Global Markets

Published - Jun 2026 | Publisher - BCC Publishing | Code - BIO228B

The global market for wound care biologics is expected to grow from $7 billion in 2025 and is projected to reach $10.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2025 to 2030.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Jun 2026 | Publisher - BCC Publishing | Code - BIO099G

The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at $8.3 billion in 2025 and, is estimated to reach $9.2 billion by 2026 and $16.3 billion by 2031, at a compound annual growth rate (CAGR) of 12.2% from 2026 through 2031.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Global Markets for Protein Labeling

Published - May 2026 | Publisher - BCC Publishing | Code - BIO154B

The global market for protein labeling is expected to grow from $2.6 billion in 2025 and is projected to reach $4.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

2025 DNA and RNA Synthesis Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - BIO265B

Discover the 2025 DNA and RNA Synthesis Research Review from BCC Research with insights into market developments, innovation trends and strategic opportunities.

Top Trending Reports

2025 Medical Devices Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - MDS060C

Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Glass Fiber: Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - AVM225B

The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.

2025 Chemical Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - CHM190B

BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.

Published - May-2005| Analyst - Melissa Elder| Code - BIO043C

Report Highlights

  • The total U.S. market for new therapeutics and diagnostics for women’s disorders was estimated at more than $25 billion in 2004 and is expected to reach nearly $41 billion in 2009, rising at an AAGR (average annual growth rate) of 10.3%.
  • Treatments for cancers specific to women will rise the fastest, at an AAGR of 12.6% and will lead revenues in 2009.
  • Reproductive-related therapies and diagnostics currently represent the largest market segment, but, rising at an AGR of 8.4%, will lag slightly by 2009.
  • Treatments for gynecological diseases and infections and for rheumatoid arthritis and osteoporosis also represent large market segments.
Published - Jan-2001| Analyst - Mary Anne Crandall| Code - BIO043B

Report Highlights

  • The total current U.S. market for new therapeutics and diagnostics for women's disorders in 1999 reached $16.9 billion at the manufacturers' level. The growing numbers of women combined with the growing trend to take an active role in healthcare has driven growth in this market. By 2005, it is anticipated that revenues will likely reach $31.9 billion, growing at an average annual rate of 8.7%.
  • The reproductive-related therapeutics and diagnostics holds the largest market revenues position representing 31.9% and accounting for $5.4 billion of the total in 1999. Large numbers of women in the baby boomer age group, coupled with large numbers of the mini-boomers (daughters of the baby boomer generation), contributed to the reproductive-related therapeutics and diagnostics' dominate role in 1999. It is anticipated that the reproductive-related therapeutics and diagnostics will remain the largest market share throughout the forecast period as it crosses $10 billion by 2005.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Therapeutics and Diagnostics for Women's Disorders
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment